Johnson & Johnson
As of Oct 23, 2026 close
- Market cap
- $645.97B
- P/E (TTM)
- 30.71
- Forward P/E
- 33.41
- Dividend yield
- 1.97%
- 52-week range
- $184.66$281.07
- Volume (live)
- -
- Avg. volume (3M)
- 7.20M
Johnson & Johnson (JNJ) Stock Price & Financial Analysis
Johnson & Johnson Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $262.40 - $266.03 |
|---|---|
| 52-Week High | $281.07 |
| 52-Week Low | $184.66 |
| Open | $265.82 |
| Volume (last close) | 5.31M |
| Average Volume (3M) | 7.20M |
| Revenue (TTM) | 99.33B |
|---|---|
| Net Income (TTM) | 21.04B |
| Free Cash Flow (TTM) | 18.32B |
| EPS (TTM) | $8.63 |
| Profit Margin | 21.18% |
| Operating Margin | 26.43% |
| Return on Equity (ROE) | 24.76% |
| Debt to Equity | 0.58 |
| Annual Dividend | $5.28 |
|---|---|
| Dividend Yield | 1.97% |
| Payout Ratio | 61.20% |
| Next Dividend Ex-Date | Nov 24, 2026 |
| Market Cap | 645.97B |
|---|---|
| Shares Outstanding | 2.45B |
| P/E Ratio (TTM) | 30.71 |
| Forward P/E | 33.41 |
| Price to Sales (P/S) | 6.50 |
| Price to Book (P/B) | 7.60 |
| EV/EBITDA | 20.87 |
| 50-Day MA | $265.07 |
|---|---|
| 200-Day MA | $244.61 |
| 1-Year Change | +39.04% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Johnson & Johnson at a Glance
As of the Oct 23, 2026 close, Johnson & Johnson (JNJ) has a market capitalization of $645.97B. The stock trades at 30.7× trailing earnings, 33.4× forward earnings and 6.5× sales. Over the trailing twelve months it earned $21.04B on revenue of $99.33B (a 21.2% profit margin) and generated $18.32B of free cash flow. Revenue grew 7.8% year over year.
As of its latest reported balance sheet, it holds $20.42B in cash and securities against $49.04B of debt, a net debt position of $28.61B.
Johnson & Johnson pays a quarterly dividend totaling $5.28 per share a year, a 1.97% yield at the Oct 23, 2026 close, with a 61% payout ratio and 55 consecutive years of dividend increases.
The share price is up 39.0% over the past year. At $263.81 (the Oct 23, 2026 close) it sits within its 52-week range of $184.66 to $281.07, above its 200-day moving average of $244.61.
Based on 30 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $279.89, 6.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Johnson & Johnson
What is the current stock price for JNJ?
As of the Oct 23, 2026 close, JNJ stock trades at $263.81. The 52-week range is $184.66–$281.07, with a day range of $262.40–$266.03.
What is the P/E ratio for JNJ?
As of the Oct 23, 2026 close, Johnson & Johnson's trailing twelve-month (TTM) P/E ratio is 30.7, meaning investors pay $30.7 for every $1 of annual earnings. The forward P/E is 33.4, reflecting analyst expectations for future earnings. Johnson & Johnson operates in the Healthcare sector.
Does JNJ pay dividends?
Yes, Johnson & Johnson pays a 1.97% annual dividend yield as of the Oct 23, 2026 close ($5.28 per share a year). The trailing twelve-month payout ratio is 61.2%. The next ex-dividend date is November 24, 2026.
What do analysts recommend for JNJ?
Based on ratings from 30 professional analysts over the last 90 days, the consensus for JNJ is Buy. The average 12-month price target is $279.89, a 6.1% upside from the Oct 23, 2026 close of $263.81.
What is the market cap of JNJ?
As of the Oct 23, 2026 close, Johnson & Johnson's market capitalization is $645.97B, classifying it as a mega-cap company. Johnson & Johnson operates in the Healthcare sector within the Drug Manufacturers - General industry.